OM DETTA AVSNITT

Engelsk
USA

UTSKRIFT 🔗

SÖK TIDIGARE AVSNITT

Sök efter tidigare avsnitt från Oncotarget.

ANDRA EPISODER I DENNA PODCAST

BUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?” The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and res…
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge in head and neck cancer care. Human papillomavirus (HPV), particularly HPV type…
Cancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how they interact with immune cells in the surrounding tumor microenvironment. Melanoma is particularly responsive to immune-based mechanisms, making it important to understand the molecular processes …
BUFFALO, NY – September 9, 2026 – A new #review was #published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.” The review examines emerging strategies to restore major histocompatibility complex class I (MHC-I) expression in cancers of the ce…
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention Center in Providence. The two-day symposium, themed “Precision Oncology: Innova…
Ansvarsfriskrivning: Podcasten och konstverket som är inbäddat på den här sidan är från Oncotarget Podcast, som är dess ägares egendom och inte anslutet till eller godkänt av Listen Notes, Inc.